Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor Xa Inhibitor”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Not applicableStudy completedNCT05898412
What this trial is testing

Retrospective Study on Characteristics and Outcomes in Hospitalised Patients Treated With Ondexxya

Who this might be right for
Hemorrhage
AstraZeneca 217
Post-approval studies (Phase 4)Looking for participantsNCT07521332
What this trial is testing

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Who this might be right for
CirrhosisEsophageal and Gastric VaricesAscites+3 more
Asian Institute Of Medical Sciences 220
Large-scale testing (Phase 3)Ended earlyNCT02179177
What this trial is testing

Apixaban in Patients With Sickle Cell Disease

Who this might be right for
Vaso-occlusive CrisisReduction in HospitalizationsSickle Cell Disease
Nirmish Shah 16
Testing effectiveness (Phase 2)Study completedNCT00402467
What this trial is testing

An Oral, Direct Factor Xa Inhibitor, BAY59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study

Who this might be right for
Venous Thromboembolism
Bayer 613
Not applicableStudy completedNCT06147830
What this trial is testing

Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

Who this might be right for
Major Bleeding
AstraZeneca 2,202
Testing effectiveness (Phase 2)Study completedNCT00973323
What this trial is testing

BAY59-7939 Japanese in Atrial Fibrillation (2nd)

Who this might be right for
Atrial Fibrillation
Bayer 100
Testing effectiveness (Phase 2)Study completedNCT00973245
What this trial is testing

BAY59-7939 in Atrial Fibrillation Once Daily (OD)

Who this might be right for
Atrial Fibrillation
Bayer 102
Large-scale testing (Phase 3)Study completedNCT00439777
What this trial is testing

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study

Who this might be right for
Pulmonary Embolism
Bayer 4,833
Large-scale testing (Phase 3)Study completedNCT01181102
What this trial is testing

DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Daiichi Sankyo Co., Ltd. 716
Testing effectiveness (Phase 2)Study completedNCT00742859
What this trial is testing

Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin

Who this might be right for
Atrial Fibrillation
Portola Pharmaceuticals 508
Post-approval studies (Phase 4)Ended earlyNCT02945280
What this trial is testing

Apixaban for Routine Management of Upper Extremity Deep Venous Thrombosis

Who this might be right for
Deep Venous ThrombosisUpper Extremity Deep Venous ThrombosisThrombus+2 more
Intermountain Health Care, Inc. 52
Testing effectiveness (Phase 2)Study completedNCT04640181
What this trial is testing

Factor Xa Inhibitor Versus Standard of Care Heparin in Hospitalized Patients With COVID-19 (XACT)

Who this might be right for
Covid19
St. David's HealthCare 150
Post-approval studies (Phase 4)Looking for participantsNCT04258488
What this trial is testing

Long-term Anticoagulation With Oral Factor Xa Inhibitor Versus Vitamin K Antagonist After Mechanical Aortic Valve Replacement

Who this might be right for
AORTIC VALVE DISEASESThromboembolism
Joon Bum Kim 1,300
Testing effectiveness (Phase 2)Study completedNCT00839826
What this trial is testing

ODiXahip - a Phase IIa Dose Escalating Proof of Principle Trial

Who this might be right for
ThromboembolismPrevention
Bayer 641
Testing effectiveness (Phase 2)Study completedNCT01203072
What this trial is testing

A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Knee Arthroplasty

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisTotal Knee Arthroplasty
Daiichi Sankyo Co., Ltd. 523
Testing effectiveness (Phase 2)Study completedNCT00839163
What this trial is testing

Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Proximal Deep Vein Thrombosis(ODIXa-DVT)

Who this might be right for
Venous ThrombosisDeep Vein Thrombosis
Bayer 613
Testing effectiveness (Phase 2)Study completedNCT00133731
What this trial is testing

The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention

Who this might be right for
Angioplasty, Transluminal, Percutaneous Coronary
Sanofi 947
Large-scale testing (Phase 3)Study completedNCT01181167
What this trial is testing

DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty

Who this might be right for
PreventionVenous Thromboembolism
Daiichi Sankyo Co., Ltd. 610
Testing effectiveness (Phase 2)Study completedNCT00408239
What this trial is testing

Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement

Who this might be right for
Thromboembolism
Astellas Pharma Inc 367
Testing effectiveness (Phase 2)Study completedNCT00395772
What this trial is testing

Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis

Who this might be right for
Venous Thromboembolism
Bayer 543
Load More Results